Immune recovery in children undergoing allogeneic stem cell transplantation: Absolute CD8+CD3+ count reconstitution is associated with survival

Bone Marrow Transplantation

Volumn 39, Issue 5, 2007, Pages 269-278

  Koehl, U ^a   Bochennek, K ^a   Zimmermann, S Y ^a   Lehrnbecher, T ^a   Sorensen J ^a   Esser, R ^a   Andreas, C ^a   Kramm, C ^a   Gruttner H P ^a   Falkenberg, E ^b   Orth, A ^b   Bader, P ^a   Schwabe, D ^a   Klingebiel, T ^a  

^a GOETHE UNIVERSITY   (Germany)

^b FRANKFURT UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD3 ANTIGEN; CD34 ANTIGEN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; THIOTEPA; THYMOCYTE ANTIBODY; TOPOTECAN;

ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HELPER CELL; HEMATOLOGIC MALIGNANCY; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PATIENT SELECTION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SURVIVOR; TREATMENT OUTCOME;

ADOLESCENT; ANTIGENS, CD3; ANTIGENS, CD8; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOCYTE COUNT; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33847254883     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705584     Document Type: Article

References (36)

1. Storek J, Gooley T, Whiterspoon RP, Sullivan KM, Storb R. Infectious morbidity in long term survivors of allogeneic marrow transplantation is associated with lower CD4T cell counts. Am J Haematol 1997; 54: 131-138.
2. Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A et al. Late infections after allogeneic bone marrow transplantation: Comparison of incidence in related and unrelated donor transplant recipients. Blood 1995; 86: 3979-3986.
3. Kook H, Goldman F, Padley D, Giller R, Rumelhart S, Holida M et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 1996; 88: 1088-1097.
4. Maraninchi D, Gluckman E, Blaise D, Guyotat D, Rio B, Pico JL et al. Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukemias. Lancet 1987; 2: 175-178.
5. + selected PBSC grafts, unselected PBSC grafts or BM grafts. Bone Marrow Transplant 1999; 24: 295-302.
6. Kalwak K, Gorczynska E, Toporski J, Turkiewicz D, Slociak M, Ussowicz M et al. Immune reconstitution after haemotopoietic cell transplantation in children: Immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 2002; 118: 74-89.
7. Ottinger HD, Beelen DW, Scheulen B, Scahefer UW, Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775-2779.
8. Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA et al. Immune reconstitution after allogenic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 11: 3380-3389.
9. Small TN, Papadopoulos EB, Boulad F, Black P, Castro-Malaspina H, Childs BH et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions. Blood 1999; 93: 467-480.
10. Dumont-Girard F, Roux E, van Lier RA, Hale G, Helg C, Chapuis B et al. Reconstitution of the T-cell compartment after bone marrow transplantation: Restoration of the repertoire by thymic emigrants. Blood 1998; 11: 4464-4471.
11. Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K et al. Immunophenotyping of blood lymphocytes in childhood: references values for lymphocyte subpopulations. J Pediatrics 1997; 130: 388-393.
12. Koehl U, Grunkel M, Gruettner HP, Sörensen J, Esser R, Kotchetkov R et al. Positive selection of haematopoietic progenitor cells for autologous and allogeneic transplantation in pediatric patients with solid tumors and leukemia. In: Büchner Th (ed). Transplantation in Haematology and Oncology, Vol. 1. Springer-Verlag: Berlin, 1999, pp 159-168.
13. Reimann KA, O'Gorman MR, Spritzler J, Wilkening CL, Sabath DE, Helm K et al. Multisite comparison of CD4 and CD8 T-lymphocyte counting vy single-versus multi-platform methodologies: Evaluation of Beckman Coulter flowcount fluorespheres and the tetraOne system. Clin Diagn Lab Immunol 2000; 7: 333-335.
14. Hajek J. Theory of Rank Tests. Academic Press: New York, San Francisco, London, 1999, pp 61.
15. Hollander M, Wolfe DA. Nonparametric Statistical Methods. Wiley: New York, 1973, pp 45.
16. Moretta L, Mingari MC, Bottino C, Pende D, Biassoni R, Moretta A. Cellular and molecular basis of natural killer and natural killer-like activity. Immunol Lett 2003; 88: 89-93.
17. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100.
18. Roux E, Dumont-Girard F, Starobinski M, Siegrist CA, Helg C, Chapuis B et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplanstation depends on thymic activity. Blood 2000; 96: 2299-2303.
19. Eyrich M, Leiler C, Lang P, Schilbach K, Shumm M, Bader P et al. A prospective comparison of immune reconstitution in pediatric patients of positively selected CD34+ peripheral blood stem cells from unrelated donors versus recipients of unmanipulated bone marrow from related donors. Bone Marrow Transplant 2003; 4: 379-396.
20. Nakamura R, Bahceci E, Read EJ, Leitman SF, Carter CS, Childs R et al. Transplant dose of CD34+ and CD3+ cells predicts outcome inpatients with haematological malignancies undergoing T-cell depleted peripheral blood stem cell transplants with delayed dondor lymphocyte add-back. Br J Haematol 2001; 115: 95-104.
21. Fallen PR, McGreavey L, Madrigal JA, Potter M, Ethell M, Prentice HG et al. Factors affecting reconstitution of the T-cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 2003; 32: 1001-1014.
22. Kook H, Goldman F, Giller R, Goeken N, Peters C, Comito M et al. Reconstitution of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation. in children: Functional analysis of lymphocytes and correlation with immunophenotypic recovery following transplantation. Clin Diagn Lab Immunol 1997; 4: 96-103.
23. Powles R, Singhal S, Treleaven J, Kulkarni S, Horton C, Mehta J. Identification of patients who may benefit from prophylactic immunotheraphy after bone marrow transplantation for acute leukaemia on the basis of lymphocyte recovery early after transplantation. Blood 1998; 11: 3481-3486.
24. Elmaagacli AH, Peceny R, Steckel N, Trenschel R, Ottinger H, Grosse-Wilde H et al. Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukaemia. Blood 2003; 15: 446-453.
25. Niehues T, Rocha V, Filipovich AH, Chan KW, Porcher R, Michel G et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children - a Eurocord analysis. Br J Haematol 2001; 114: 42-48.
26. Kalwak K, Moson I, Cwian J, Gorczynska E, Toporski J, Turkiewicz D et al. A prospective analysis of immune recovery in children following allogenic transplantation of T-cell depleted or non-depleted hematopoietic cells from HLA-disparate family donors. Transplant Proc 2003; 35: 1551-1555.
27. Gratama JW, Naipal A, Oljans P, Zwaan FE, Verdonck LF, de Witte T et al. T-Lymphocyte repopulation and differentiation after bone marrow transplantation. Early shifts in the ratio between T4 and T8 T-lymphocytes correlate with the occurance of GVHD. Blood 1984; 64: 1416-1423.
28. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995; 16: 413-425.
29. Eyrich M, Lang P, Lal S, Bader P, Handgretinger R, Klingebiel T et al. A prospective analysis of immune reconstitution following transplantation of positively selected human leukocyte antigen-disparate haematopoietic stem cells from parental donors. Br J Haematol 2001; 114: 422-432.
30. De Vries E, van Tol MJ, van den Berg RL, Waaijer JL, ten Dam MM, Hermans J et al. Reconstitution of lymphocyte subpopulations after pediatric bone marrow transplantation. Bone Marrow Transplant 2000; 90: 86-93.
31. Kim DH, Kim JG, Sohn SK, Sung WJ, Suh JS, Lee KS et al. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol 2004; 125: 217-224.
32. Passweg JR, Stern M, Koehl U, Uharek L, Tichelli A. Use of natural killer cells in hematopoetic stem cell transplantation. Bone Marrow Transplant 2005; 17: 15-21.
33. Koehl U, Sörensen J, Esser R, Zimmerman S, Grüttner HP, Tonn T et al. IL-2 activated NK cell immunotheraphy in three children after haploidentical stem cell transplantation. Blood Cells Mol Dis 2004; 33: 261-266.
34. Abrahamsen IW, Somme S, Heldal D, Egeland T, Kvale D, Tjonnfjord GE et al. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. Haematologica 2005: 25: 267-275.
35. Novitzky N, Davison GM, Hale G, Waldmann H. Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome. Transplantation 2002; 74: 1551-1159.
36. Bonnet D, Warren EH, Greenberg PD, Dick JE, Riddell SR. CD8+ minor histocompatibility antigen-specific cytotoxic T-lymphocycte clones eliminate human acute myeloid leukaemia stem cells. Proc Natl Acad Sci USA 1999; 96: 8639-8644.